Masashi Ando

4.8k total citations
206 papers, 3.6k citations indexed

About

Masashi Ando is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Masashi Ando has authored 206 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 75 papers in Pulmonary and Respiratory Medicine and 49 papers in Surgery. Recurrent topics in Masashi Ando's work include Gastric Cancer Management and Outcomes (31 papers), Breast Cancer Treatment Studies (29 papers) and Cancer Treatment and Pharmacology (29 papers). Masashi Ando is often cited by papers focused on Gastric Cancer Management and Outcomes (31 papers), Breast Cancer Treatment Studies (29 papers) and Cancer Treatment and Pharmacology (29 papers). Masashi Ando collaborates with scholars based in Japan, United States and United Kingdom. Masashi Ando's co-authors include Yasuhiro Fujiwara, Noriyuki Katsumata, Kan Yonemori, Kenji Tamura, Chikako Shimizu, Toru Watanabe, Takayuki Kinoshita, Mayu Yunokawa, Masaru Narabayashi and Tsutomu Kouno and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Masashi Ando

190 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Masashi Ando 2.0k 954 774 688 431 206 3.6k
Patrizia Vici 1.9k 0.9× 680 0.7× 782 1.0× 867 1.3× 285 0.7× 206 3.6k
Gerardo Colón‐Otero 2.0k 1.0× 608 0.6× 528 0.7× 595 0.9× 618 1.4× 99 3.5k
Glenn Mills 1.9k 0.9× 930 1.0× 448 0.6× 673 1.0× 340 0.8× 119 3.4k
Bhawna Sirohi 1.7k 0.8× 792 0.8× 514 0.7× 817 1.2× 514 1.2× 171 3.8k
N. Tubiana-Mathieu 2.0k 1.0× 644 0.7× 630 0.8× 436 0.6× 338 0.8× 166 3.2k
Enzo Galligioni 1.7k 0.8× 1.2k 1.3× 720 0.9× 1.1k 1.5× 509 1.2× 166 3.5k
Adnan Ghafoor 1.5k 0.7× 907 1.0× 512 0.7× 891 1.3× 567 1.3× 3 3.2k
Pilar Garrido 2.1k 1.0× 1.9k 2.0× 610 0.8× 909 1.3× 402 0.9× 291 3.9k
Ishmael Jaiyesimi 1.3k 0.6× 784 0.8× 537 0.7× 632 0.9× 277 0.6× 119 3.1k
Ondřej Topolčan 1.6k 0.8× 1.0k 1.1× 1.1k 1.4× 1.3k 1.9× 622 1.4× 254 4.2k

Countries citing papers authored by Masashi Ando

Since Specialization
Citations

This map shows the geographic impact of Masashi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ando more than expected).

Fields of papers citing papers by Masashi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ando. The network helps show where Masashi Ando may publish in the future.

Co-authorship network of co-authors of Masashi Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ando. A scholar is included among the top collaborators of Masashi Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ando. Masashi Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishikawa, Tadaaki, Shigeki Kakunaga, Kenji Tamura, et al.. (2024). Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510). Cancer. 130(22). 3836–3844. 2 indexed citations
2.
Narita, Yukiya, Toshiki Masuishi, Hiroya Taniguchi, et al.. (2024). Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study. The Oncologist. 30(7). 3 indexed citations
3.
Fukuda, Takashi, et al.. (2023). Dietary vanillic acid prevents postmenopausal symptoms in ovariectomized mice. Food Science and Technology Research. 30(1). 97–106.
4.
Kodama, Hiroyuki, Shigenori Kadowaki, Takatsugu Ogata, et al.. (2023). O9-1 Paclitaxel plus cetuximab vs. nivolumab for patients with platinum-refractory recurrent/metastatic head and neck cancer. Annals of Oncology. 34. S1388–S1388.
5.
Iwase, Madoka, Masashi Ando, Kenjiro Aogi, et al.. (2020). Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer Research and Treatment. 180(3). 687–694. 22 indexed citations
6.
Kawai, Akira, Toshio Goto, Tatsuhiro Shibata, et al.. (2018). Current state of therapeutic development for rare cancers in Japan, and proposals for improvement. Cancer Science. 109(5). 1731–1737. 9 indexed citations
7.
8.
Nakamura, Seigo, Masashi Ando, Norikazu Masuda, et al.. (2011). Randomized Phase II Study of Primary Systemic Chemotherapy and Trastuzumab for Operable HER2 Positive Breast Cancer. Clinical Breast Cancer. 12(1). 49–56. 6 indexed citations
9.
Shigematsu, Hiroshi, Toshiya Nishibe, Yukio Obitsu, et al.. (2010). Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).. PubMed. 29(2 Suppl). 2–13. 12 indexed citations
10.
Tanioka, Maki, Carlos Shimizu, Kan Yonemori, et al.. (2010). Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy. British Journal of Cancer. 103(3). 297–302. 44 indexed citations
11.
Tamura, Kenji, Chikako Shimizu, Takashi Hojo, et al.. (2010). FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer. Annals of Oncology. 22(6). 1302–1307. 139 indexed citations
12.
Yonemori, Kan, Koji Tsuta, Chikako Shimizu, et al.. (2010). Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy. Journal of Surgical Oncology. 101(3). 222–227. 17 indexed citations
13.
Ono, Makiko, Masashi Ando, Mayu Yunokawa, et al.. (2009). Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. International Journal of Clinical Oncology. 14(1). 48–52. 30 indexed citations
14.
Shimizu, Ken, Yuki Ishibashi, Shino Umezawa, et al.. (2009). Feasibility and usefulness of the ‘Distress Screening Program in Ambulatory Care’ in clinical oncology practice. Psycho-Oncology. 19(7). 718–725. 59 indexed citations
15.
Shimizu, Carlos, Kan Yonemori, Akihiro Hirakawa, et al.. (2009). Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer. British Journal of Cancer. 101(9). 1529–1536. 83 indexed citations
16.
17.
Shimizu, Chikako, Kenichi Yoshimura, Hitoshi Tsuda, et al.. (2009). Long-term Outcome and Pattern of Relapse after Neoadjuvant Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 2-positive Primary Breast Cancer. Japanese Journal of Clinical Oncology. 39(8). 484–490. 14 indexed citations
18.
Kawano, Osamu, Hirotsugu Kohrogi, Yukio Ando, et al.. (1997). Bronchial Hyperreactivity in Patients With Familial Amyloidotic Polyneuropathy and Autonomic Neuropathy. American Journal of Respiratory and Critical Care Medicine. 155(4). 1465–1468. 1 indexed citations
19.
Ando, Masashi, H. Suginami, & Shinya Matsuura. (1989). 460 Contribution of embryo-derived platelet activating factor in pregnancy establishment in mice : a study with a PAF antagonist, CV-6209. :. 日本産科婦人科學會雜誌. 41(8). 1246. 1 indexed citations
20.
Ando, Masashi, et al.. (1986). Regulation of HCL secretion in the eel stomach. ZOOLOGICAL SCIENCE. 3(3). 429–436. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Vici Breakdown of academic impact, for papers by Gerardo Colón‐Otero Breakdown of academic impact, for papers by Glenn Mills Breakdown of academic impact, for papers by Bhawna Sirohi Breakdown of academic impact, for papers by N. Tubiana-Mathieu Breakdown of academic impact, for papers by Enzo Galligioni Breakdown of academic impact, for papers by Adnan Ghafoor Breakdown of academic impact, for papers by Pilar Garrido Breakdown of academic impact, for papers by Ishmael Jaiyesimi Breakdown of academic impact, for papers by Ondřej Topolčan
Rankless by CCL
2026